Adhera Therapeutics, Inc. appointed Andrew Kucharchuk as the Company's Chief Operating Officer, effective September 30, 2022. Mr. Kucharchuk will continue to serve as the Company's Chief Executive Officer until September 30, 2022. Mr. Kucharchuk, 41, has served as the Chairman of Board and Chief Executive Officer since July 7, 2020.

He has also served on the Board of Directors of Theralink Technologies, Inc. since 2020 after previously serving in such role from September 2015 to March 2017. Previously, he served as President and Chief Financial Officer of Theralink from February 2016 until June 2020, as Chief Executive Officer of Theralink from November 2019 until June 2020, and as Chief Financial Officer of Theralink from 2009 to September 2015. Mr. Kucharchuk has also served as Acting Chief Financial Officer of Theralink from June 2020 to September 2020.